Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
3,970.00
-45.00 (-1.12%)
At close: Mar 6, 2026
-48.37% (1Y)
| Market Cap | 179.62B |
| Revenue (ttm) | 66.40B |
| Net Income (ttm) | -28.37B |
| Shares Out | 49.55M |
| EPS (ttm) | -566.79 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 209,810 |
| Average Volume | 526,628 |
| Open | 4,010.00 |
| Previous Close | 4,015.00 |
| Day's Range | 3,820.00 - 4,070.00 |
| 52-Week Range | 3,655.00 - 8,800.00 |
| Beta | -0.72 |
| RSI | 45.62 |
| Earnings Date | Mar 20, 2026 |